CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
1.590
-0.050 (-3.04%)
Oct 26, 2026, 10:16 AM EDT - Market open
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $27.97 million as of October 26, 2026. It is the 34,222nd most valuable company in the world and the 5,001st biggest in the United States. Its market cap has decreased by 55.61% in one year.
Market Cap
27.97M
Enterprise Value
29.33M
1-Year Change
-55.61%
Global Rank
Country Rank
#5,001 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, CEL-SCI's market cap has increased from $27.40M to $27.97M, an increase of 2.07%. That is a compound annual growth rate of 0.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 27.97M | -36.72% |
| Dec 31, 2025 | 44.20M | 79.67% |
| Dec 31, 2024 | 24.60M | -81.90% |
| Dec 29, 2023 | 135.90M | 32.46% |
| Dec 30, 2022 | 102.60M | -66.58% |
| Dec 31, 2021 | 307.00M | -33.78% |
| Dec 31, 2020 | 463.60M | 43.22% |
| Dec 31, 2019 | 323.70M | 297.18% |
| Dec 31, 2018 | 81.50M | 226.00% |
| Dec 29, 2017 | 25.00M | 96.85% |
| Dec 30, 2016 | 12.70M | -73.60% |
| Dec 31, 2015 | 48.10M | -9.42% |
| Dec 31, 2014 | 53.10M | 80.61% |
| Dec 31, 2013 | 29.40M | -60.16% |
| Dec 31, 2012 | 73.80M | 10.81% |
| Dec 30, 2011 | 66.60M | -60.45% |
| Dec 31, 2010 | 168.40M | 25.11% |
| Dec 31, 2009 | 134.60M | 300.60% |
| Dec 31, 2008 | 33.60M | -42.37% |
| Dec 31, 2007 | 58.30M | 27.85% |
| Dec 29, 2006 | 45.60M | 25.27% |
| Dec 30, 2005 | 36.40M | -15.74% |
| Dec 31, 2004 | 43.20M | -37.39% |
| Dec 31, 2003 | 69.00M | 845.21% |
| Dec 31, 2002 | 7.30M | -67.12% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 32.19M |
| Filana Therapeutics | 31.13M |
| BioStem Technologies | 30.66M |
| TransCode Therapeutics | 30.56M |
| Aligos Therapeutics | 30.10M |
| IRulya Therapeutics | 30.04M |
| BriaCell Therapeutics | 29.91M |
| Metagenomi Therapeutics | 29.84M |